| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $52.3M | +14.7% | +1.5% |
| Cost of Revenue | $24.7M | +13.8% | +10.0% |
| Gross Profit | $27.6M | +15.4% | -5.0% |
| R&D Expense | $9.0M | +1.5% | -9.4% |
| SG&A Expense | $16.1M | +19.1% | +47.3% |
| Operating Income | -$9.2M | +13.5% | -116.4% |
| Pre-tax Income | -$7.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $93.3M | +23.6% | -42.5% |
| Accounts Receivable | $56.6M | +0.7% | +7.6% |
| Inventory | $51.6M | +4.4% | +10.4% |
| Current Assets | $388.5M | +1.5% | -0.4% |
| Total Assets | $494.9M | +0.3% | +0.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.9M | — | — |
| Capital Expenditures | $3.1M | — | — |
| Investing Cash Flow | $12.0M | — | — |
| Financing Cash Flow | -$12.2M | — | — |
| Free Cash Flow | -$7.0M | — | — |
| -14.7% |
| -5048.4% |
| Income Tax | -$2.3M | -92.2% | -192.2% |
| Net Income | -$5.5M | +1.9% | -682.1% |
| $75.2M |
| +2.6% |
| +19.8% |
| Total Liabilities | $116.3M | +0.5% | +10.0% |
| Stockholders' Equity | $378.6M | +0.3% | -1.8% |